These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 20153665

  • 1. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis.
    Soto-Sánchez J, Santos-Juanes J, Coto-Segura P, Coto E, Díaz M, Rodríguez I, Alvarez V.
    Cytokine; 2010 May; 50(2):114-6. PubMed ID: 20153665
    [Abstract] [Full Text] [Related]

  • 2. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.
    González P, Alvarez R, Batalla A, Reguero JR, Alvarez V, Astudillo A, Cubero GI, Cortina A, Coto E.
    Genes Immun; 2001 Jun; 2(4):191-5. PubMed ID: 11477473
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
    Tan XH, Zhang JY, Di CH, Hu AR, Yang L, Qu S, Zhao RL, Yang PR, Guo SX.
    Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
    [Abstract] [Full Text] [Related]

  • 5. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M, Ardlie K, Wacholder S, Welch R, Chanock S, O'Brien TR.
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [Abstract] [Full Text] [Related]

  • 6. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ, Smoleń J, Kruszyński P, Bratosiewicz-Wasik J, Beniowski M.
    Wiad Lek; 2005 Jan; 58(9-10):500-7. PubMed ID: 16529059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG, Lima G, Gabilondo F, Llorente L.
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [Abstract] [Full Text] [Related]

  • 9. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M, Doroudchi M, Farjadian S, Pezeshki AM, Ghaderi A.
    Immunol Lett; 2005 Jan 31; 96(2):277-81. PubMed ID: 15585333
    [Abstract] [Full Text] [Related]

  • 10. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
    Wang F, Jin L, Lei Z, Shi H, Hong W, Xu D, Jiang J, Wang Y, Zhang B, Liu M, Li Y.
    Chin Med J (Engl); 2001 Nov 31; 114(11):1162-6. PubMed ID: 11729511
    [Abstract] [Full Text] [Related]

  • 11. CCR2-64I is a risk factor for development of bladder cancer.
    Narter KF, Agachan B, Sozen S, Cincin ZB, Isbir T.
    Genet Mol Res; 2010 Apr 13; 9(2):685-92. PubMed ID: 20449800
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus.
    Aguilar F, Núñez-Roldán A, Torres B, Wichmann I, Sánchez-Román J, González-Escribano MF.
    J Rheumatol; 2003 Aug 13; 30(8):1770-4. PubMed ID: 12913933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
    Zheng B, Wiklund F, Gharizadeh B, Sadat M, Gambelunghe G, Hallmans G, Dillner J, Wallin KL, Ghaderi M.
    Anticancer Res; 2006 Aug 13; 26(5B):3669-74. PubMed ID: 17094383
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.
    Breunis WB, Biezeveld MH, Geissler J, Kuipers IM, Lam J, Ottenkamp J, Hutchinson A, Welch R, Chanock SJ, Kuijpers TW.
    Clin Exp Immunol; 2007 Oct 13; 150(1):83-90. PubMed ID: 17672867
    [Abstract] [Full Text] [Related]

  • 18. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.
    Huerta C, Alvarez V, Mata IF, Coto E, Ribacoba R, Martínez C, Blázquez M, Guisasola LM, Salvador C, Lahoz CH, Peña J.
    Neurosci Lett; 2004 Nov 11; 370(2-3):151-4. PubMed ID: 15488313
    [Abstract] [Full Text] [Related]

  • 19. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.
    Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Venturelli E, Cutter GR, Mariani C, Forloni G, Pettenati C, Baron P, Conti G, Bresolin N, Scarpini E.
    J Neurol Sci; 2004 Oct 15; 225(1-2):79-83. PubMed ID: 15465089
    [Abstract] [Full Text] [Related]

  • 20. Determination of the CCR2-64I/CCR5-59653T haplotype linkage disequilibrium in a sample of Polish population.
    Lewandowska M, Trzeciak WH, Jagodzinski PP.
    Genetika; 2003 Jun 15; 39(6):831-3. PubMed ID: 12884524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.